Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX.DL)

CAPS Rating: No stars

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ONXX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

7ayyan (< 20)
Submitted April 18, 2012

Many promising drugs in pipeline

iamjign (< 20)
Submitted July 08, 2013

Though attractive target, but market is too enthusiastic about it's prospect of going north of 150. Thinking it may stay around $130 mark.

NASDAQ:ONXX.DL VS S&P 500 (SPY)

NASDAQ:ONXX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ONXX.DL.

No one has written a Pitch for ONXX.DL stock yet. Tell us why you think ONXX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in ONXX.DL.

No players have picked ONXX.DL yet. Tell us why you think ONXX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ONXX.DL.